CTOs on the Move

Milestone Scientific

www.milestone.com

 
Milestone Scientific Inc. (MLSS) is a biomedical technology research and development company that patents, designs and develops innovative diagnostic and therapeutic injection technologies and instruments for medical, dental, cosmetic and veterinary applications. Milestone`s computer-controlled systems are designed to make injections precise, efficient, and virtually painless. Milestone`s proprietary DPS Dynamic Pressure Sensing technology® is our technology platform that advances the development of next-generation devices, regulating flow rate and monitoring pressure from the tip of the needle, through platform extensions for local anesthesia for subcutaneous drug delivery, with specific applications for cosmetic botulinum toxin injections, epidural space identification in regional anesthesia procedures ...
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million
  • www.milestone.com
  • 425 Eagle Rock Avenue Suite 403
    Roseland, NJ USA 07068
  • Phone: 973.535.2717

Executives

Name Title Contact Details

Similar Companies

RadiaShield

RadiaShield is a New York, NY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Typenex Medical

The Typenex® Medical advantage is connecting with our customers to understand their process needs, then to deliver simple, high-quality products that streamline workflows. Our strength is providing customers the help they need to make sure their process is successful. We think about efficiency and cost-effectiveness, along with patient safety and patient comfort, while providing a quality product. We thoroughly understand the invaluable nature of training and customer service.

MY01

MY01 is a state-of-the-art medical device geared towards aiding in the detection of Compartment Syndrome (CS); a limb-threatening muscle condition that occurs within 48 hours following trauma. Currently, ACS is diagnosed based on subjective and unreliable outcomes like pain (known as 6 P`s), which when present cannot confirm the diagnosis in time for effective intervention. This leads to increased complications (muscle necrosis/amputation) and costs the US healthcare system more than $2.25 B annually. MY01 is capitalizing on a proven correlation between sustained increase in Intramuscular pressures and ACS for objective, early diagnosis. MY01 operationalizes muscular pressure monitoring into a simple, accurate single-use device. MY01. The simple solution to a dangerous problem.

BioHorizons

BioHorizons is one of the leading companies in the Healthcare, Pharmaceuticals, and Biotech sector.

Nanomix

Our Vision is to make healthcare accessible to patients, without compromise, by delivering the highest quality, fastest, cost effective and portable detection systems that bring the patient and caregiver closer together.